Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lower Urinary Tract Symptoms
Open-data reference.
22 US clinical trials · 7 currently recruiting
Active & Recent Trials
BPH Global Registry
Société Internationale d'Urologie
NCT05543200
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Beth Israel Deaconess Medical Center
NCT04288427
US Imaging for the Assessment of LUTS
University of Wisconsin, Madison
NCT06323109
PRescription Exercise for Older Men With Urinary Disease
University of California, San Francis
NCT06225479
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
Iman Al-Naggar, PhD
NCT06351683
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
The Cleveland Clinic
NCT06179654
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
University of Kansas Medical Center
NCT03802851
LURN: Urinary Urgency Phenotyping Protocol
Arbor Research Collaborative for Health
NCT04557748
INTIBIA Pivotal Study
Coloplast A/S
NCT05250908
Use of Artificial Intelligence by Urogynecologic Patients
Hartford Hospital
NCT06481436
RISE FOR HEALTH Study
University of Minnesota
NCT05365971
Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study
Arbor Research Collaborative for Health
NCT02485808
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
Boehringer Ingelheim
NCT01726270
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
Astellas Pharma
NCT00507455
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
University of Alabama at Birmingham
NCT01175382
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
Medstar Health Research Institute
NCT02748317
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
Chesapeake Urology Research Associates
NCT00893113
GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
ConvaTec
NCT05470751
Urological Biofeedback Game Software
University of Wisconsin, Madison
NCT02758938
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
Baylor Research Institute
NCT03817931
Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder
The Methodist Hospital Research Institute
NCT03033355
Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Light Sciences Oncology
NCT00709488
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
| Phase 2 | 5 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Lower Urinary Tract Symptoms Trial Landscape
ClinicalTrials.gov lists 22 US studies indexed under Lower Urinary Tract Symptoms, and 7 of those are currently open to recruitment — roughly 32% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Lower Urinary Tract Symptoms shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 6 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Lower Urinary Tract Symptoms is led by Arbor Research Collaborative for Health with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 22 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Lower Urinary Tract Symptoms?
PlainTrial tracks 22 US clinical trials for Lower Urinary Tract Symptoms, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Lower Urinary Tract Symptoms?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.